Neuromyelitis optica spectrum disorders: still evolving and broadening

2019160 citationsReviewhybrid Open Access

Authors

Kazuo Fujihara · Southern Tohoku General Hospital

Abstract

The clinical, pathological and therapeutic concepts of NMOSD have evolved and broadened over the last two decades following the detection of AQP4 antibodies and MOG antibodies in the patients. Double seronegative NMOSD is a current research focus, but now we may need to reconsider how NMOSD should be defined.

Topics & Keywords

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Systemic Lupus Erythematosus Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Opinion in Neurology

Volume 32, Issue 3, pp. 385-394

DOI: 10.1097/wco.0000000000000694

Field-Weighted Citation Impact: 15.67